Literature DB >> 1709544

Opsonic monoclonal antibodies against lipopolysaccharide (LPS) antigens of Pasteurella multocida and the role of LPS in immunity.

B Adler.   

Abstract

A panel of six monoclonal antibodies (MAbs) produced from mice immunized with Pasteurella multocida (M1404) (Heddleston serotype 2) reacted with homologous lipopolysaccharide, as indicated by enzyme immunoassay and immunoblotting. All six MAbs reacted with serotypes 2 and 5 of the 16 Heddleston serotypes. The reactive epitopes were localized on the bacterial cell surface by immunogold labelling. The antibodies could agglutinate P. multocida only if cells were first treated with 1 N HCl. All six MAbs opsonized P. multocida for phagocytosis by mouse macrophages but were not bactericidal in the presence of complement. They afforded only partial protection against infection in mice. The results, together with those of active immunization experiments with LPS, suggest a subordinate role for LPS in protection from experimental infection in mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709544     DOI: 10.1016/0378-1135(91)90027-d

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

1.  Detection of Antibodies to Pasteurella multocida by capture enzyme immunoassay using a monoclonal antibody against P37 antigen.

Authors:  R R Peterson; B J Deeb; R F DiGiacomo
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity.

Authors:  A Midwinter; T Vinh; S Faine; B Adler
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

3.  The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).

Authors:  J D Boyce; B Adler
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Authors:  M Vasfi Marandi; K R Mittal
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen.

Authors:  C G Ruffolo; B Adler
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.

Authors:  J D Boyce; B Adler
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Structural and genetic basis for the serological differentiation of Pasteurella multocida Heddleston serotypes 2 and 5.

Authors:  Frank St Michael; Marina Harper; Henrietta Parnas; Marietta John; Jacek Stupak; Evgeny Vinogradov; Ben Adler; John D Boyce; Andrew D Cox
Journal:  J Bacteriol       Date:  2009-09-18       Impact factor: 3.490

8.  A heptosyltransferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence.

Authors:  Marina Harper; Andrew D Cox; Frank St Michael; Ian W Wilkie; John D Boyce; Ben Adler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Evaluation of Pasteurella multocida serotype B:2 resistance to immune serum and complement system.

Authors:  Saeed Ataei Kachooei; Mohammad Mehdi Ranjbar; Saba Ataei Kachooei
Journal:  Vet Res Forum       Date:  2017-09-15       Impact factor: 1.054

10.  Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.

Authors:  Korkiat Muangthai; Pallop Tankaew; Thanya Varinrak; Ratchanee Uthi; Suvichai Rojanasthien; Takuo Sawada; Nattawooti Sthitmatee
Journal:  J Vet Med Sci       Date:  2017-11-06       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.